GlassScriptPhysician profile
Michelle Eggart
NPI 1457157448
$427.87
in general payments reported to CMS, 2019-2025
17 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $61.09 | 2025 | |
| Geron Corporation | $46.72 | 2025 | Rytelo |
| Novartis Pharmaceuticals Corporation | $35.97 | 2025 | |
| Invivyd INC | $33.85 | 2025 | Pemgarda |
| Merck Sharp & Dohme LLC | $32.07 | 2025 | Keytruda, Lynparza |
| Adaptive Biotechnologies Corporation | $25.13 | 2025 | Clonoseq |
| Janssen Biotech, INC. | $20.30 | 2025 | Darzalex, Talvey |
| Glaxosmithkline, LLC. | $19.61 | 2025 | Ojjaara |
| Regeneron Healthcare Solutions, INC. | $19.44 | 2025 | Libtayo |
| Takeda Pharmaceuticals U.S.A., INC. | $19.38 | 2025 | Iclusig |
| Agios Pharmaceuticals, INC. | $18.36 | 2025 | Pyrukynd |
| Tersera Therapeutics LLC | $18.14 | 2025 | Xermelo |
| Karyopharm Therapeutics INC. | $17.79 | 2025 | Xpovio |
| Abbvie INC. | $15.90 | 2025 | |
| Azurity Pharmaceuticals, INC. | $15.31 | 2025 | Danziten |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmaessentia USA Corporation | $14.92 | 2025 | Besremi |
| E.R. Squibb & Sons, L.L.C. | $13.89 | 2025 | Opdivo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Eggart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.